Growth Metrics

Medpace Holdings (MEDP) Receivables (2016 - 2026)

Medpace Holdings filings provide 12 years of Receivables readings, the most recent being $418.8 million for Q1 2026.

  • On a quarterly basis, Receivables rose 37.51% to $418.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $418.8 million, a 37.51% increase, with the full-year FY2025 number at $427.4 million, up 41.63% from a year prior.
  • Receivables hit $418.8 million in Q1 2026 for Medpace Holdings, down from $427.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $427.4 million in Q4 2025 to a low of $225.9 million in Q2 2022.
  • Median Receivables over the past 5 years was $306.7 million (2023), compared with a mean of $321.5 million.
  • Biggest five-year swings in Receivables: skyrocketed 55.73% in 2022 and later decreased 5.95% in 2024.
  • Medpace Holdings' Receivables stood at $293.8 million in 2022, then grew by 9.21% to $320.9 million in 2023, then fell by 5.95% to $301.8 million in 2024, then surged by 41.63% to $427.4 million in 2025, then decreased by 2.02% to $418.8 million in 2026.
  • The last three reported values for Receivables were $418.8 million (Q1 2026), $427.4 million (Q4 2025), and $383.8 million (Q3 2025) per Business Quant data.